MedDataX Logo

Impact of Bilingual Prescription Medication Labels Among Elderly Singaporeans

NCT05101330 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-05-24

No results posted yet for this study

Summary

The proposed study aims to provide preliminary data that will enable the conduct of a larger Randomized Controlled Trial (RCT) on the impact of bilingual Prescription Medication Labels (PMLs) on 3 medication-related outcomes - medication adherence, medication management self-efficacy, and PML understanding.

Conditions

  • Diabetes Mellitus, Type 2
  • Hypertension

Interventions

DEVICE

Bilingual prescription medication labels

The bilingual PML contains English and Chinese medication-related instructions for participants.

Sponsors & Collaborators

  • Duke-NUS Graduate Medical School

    collaborator OTHER

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Giat Yeng Khee, PhD · Singapore General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-05-12
Completion
2022-05-12

Countries

  • Singapore

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05101330 on ClinicalTrials.gov